The development of cyclotron‑based radiopharmaceuticals: a comprehensive review of 64Cu and 123I‑radiolabeled urea‑based small molecule PSMA ligands; Journal of Radioanalytical and Nuclear Chemistry; Vol. 332

The development of cyclotron‑based radiopharmaceuticals: a comprehensive review of 64Cu and 123I‑radiolabeled urea‑based small molecule PSMA ligands; Journal of Radioanalytical and Nuclear Chemistry; Vol. 332

Bibliographic Details
Parent link:Journal of Radioanalytical and Nuclear Chemistry.— .— New York: Springer Science+Business Media LLC.
Vol. 332.— 2023.— P. 3523-3546
Corporate Author: Томский политехнический университет
Other Authors: Khasnovo Lutfi Aditjya, Larkina M. S. Mariya Sergeevna, Garapatski A. A. Alexander Alexandrovich, Yusubov M. S. Mekhman Suleiman-Ogly (Suleimanovich)
Summary:64Cu and 123I are attracting attention in taking up their role in the development and practical use of PSMA-targeting radiopharmaceuticals. The development of urea-based small molecule PSMA ligands labeled 64Cu and 123I has been progressing steadily with the challenge of obtaining optimal performance as PSMA-targeting radiopharmaceutical for prostate cancer. In this review, the authors provide an overview of recent research projects and future directions for the production of cyclotronbased medical radioisotopes 64Cu and 123I, and their application in the development of urea-based small molecule PSMA ligands labeled 64Cu and 123I as radiopharmaceuticals for prostate cancer.
Текстовый файл
Language:English
Published: 2023
Subjects:
64Cu
123I
PSMA
radiopharmaceuticals
prostate cancer
cyclotron
труды учёных ТПУ
электронный ресурс
Online Access:https://doi.org/10.1007/s10967-023-09048-3
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=672771

Similar Items

Similar Items